NEW YORK, NY / ACCESSWIRE / June 8, 2022 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Netflix, Inc. (NASDAQ:NFLX)
CONTACT JAKUBOWITZ ABOUT NFLX:
https://claimyourloss.com/securities/netflix-inc-loss-submission-form/?id=28257&from=1
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Netflix common stock or call options, or sold put options, between January 19, 2021 and April 19, 2022, inclusive.
Lead Plaintiff Deadline : July 5, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Netflix was exhibiting slower acquisition growth due to, among other things, account sharing by customers and increased competition from other streaming services; (2) the Company was experiencing difficulties retaining customers; (3) as a result of the foregoing, the Company was losing subscribers on a net basis (4) as a result, the Company's financial results were being adversely affected; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.
Amazon.com, Inc. (NASDAQ:AMZN)
CONTACT JAKUBOWITZ ABOUT AMZN:
https://claimyourloss.com/securities/amazon-com-inc-loss-submission-form/?id=28257&from=1
Class Period : February 1, 2019 - April 5, 2022
Lead Plaintiff Deadline : July 5, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Amazon engaged in anticompetitive conduct in its private-label business practices, including giving Amazon products preference over those of its competitors and using third-party sellers' non-public data to compete with them; (ii) the foregoing exposed Amazon to a heightened risk of regulatory scrutiny and/or enforcement actions; (iii) Amazon's revenues derived from its private-label business were in part the product of impermissible conduct and thus unsustainable; and (iv) as a result, the defendants' public statements throughout the class period were materially false and/or misleading.
Spero Therapeutics, Inc. (NASDAQ:SPRO)
CONTACT JAKUBOWITZ ABOUT SPRO:
https://claimyourloss.com/securities/spero-therapeutics-inc-loss-submission-form/?id=28257&from=1
Class Period : October 28, 2021 - May 2, 2022
Lead Plaintiff Deadline : July 25, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the data submitted in support of the New Drug Application ("NDA") for the Company's product candidate, Tebipenem HBr, were insufficient to obtain approval from the U.S. Food and Drug Administration ("FDA"); (ii) accordingly, it was unlikely that the FDA would approve the Tebipenem HBr NDA in its current form; (iii) the foregoing would necessitate a significant workforce reduction and restructuring of Spero's operations; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/704348/LAWSUITS-FILED-AGAINST-NFLX-AMZN-and-SPRO--Jakubowitz-Law-Pursues-Shareholders-Claims